In a randomized trial of patients with hepatitis C genotype 1 and - TopicsExpress



          

In a randomized trial of patients with hepatitis C genotype 1 and cirrhosis, sustained virologic response rates were achieved by 92% of patients treated with 12 weeks of three novel antivirals and 96% of patients treated the three novel antiviral plus ribavirin. Only 2% of patients discontinued treatment due to adverse events. These TURQUOISE II results are being presented at the International Liver Congress today in London, and published on NEJM.org. nej.md/1hxLTH5
Posted on: Sat, 12 Apr 2014 15:00:03 +0000

Trending Topics



Recently Viewed Topics




© 2015